Premier’s ProvideGx Secures Supply Of Drugs Vital To COVID-19 Care

By John Wilkerson / May 28, 2020 at 3:49 PM
ProvideGx secured long-term supply of two medications vital to caring for patients with COVID-19, Premier announced Thursday (May 28). Premier’s drug shortage program contracted Hikma Pharmaceuticals to supply amiodarone and sterile water. Amiodarone is used to manage heart complications common in seriously ill COVID-19 patients. It’s not on the FDA’s drug shortage list, but Premier’s purchasing data shows that just 55 percent of orders are being filled due to increase demand. Sterile water is on the American Society of Health-System...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.